Page last updated: 2024-10-31

1-(3-trifluoromethylphenyl)piperazine and Weight Gain

1-(3-trifluoromethylphenyl)piperazine has been researched along with Weight Gain in 1 studies

1-(3-trifluoromethylphenyl)piperazine: acts as serotonin agonist; structure
1-(3-(trifluoromethyl)phenyl)piperazine : A N-arylpiperazine that is piperazine substituted by a 3-(trifluoromethyl)phenyl group at position 1. A serotonergic agonist used as a recreational drug.

Weight Gain: Increase in BODY WEIGHT over existing weight.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Rouru, J1
Pesonen, U1
Isaksson, K1
Huupponen, R1
Koulu, M1

Other Studies

1 other study available for 1-(3-trifluoromethylphenyl)piperazine and Weight Gain

ArticleYear
Effect of chronic treatment with TFMPP, a 5-HT1 receptor agonist, on food intake, weight gain, plasma insulin and neuropeptide mRNA expression in obese Zucker rats.
    European journal of pharmacology, 1993, Apr-06, Volume: 234, Issue:2-3

    Topics: Animals; Autoradiography; Blood Glucose; Corticotropin-Releasing Hormone; Eating; Insulin; Male; Neu

1993